USD
+$0.00
(+0.00%
)At Close (As of Sep 8, 2025)
$158.87B
Market Cap
63.82
P/E Ratio
1.68
EPS
$108.94
52 Week High
$80.64
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $10B |
Total Revenue | $17B |
Cost Of Revenue | $6.5B |
Costof Goods And Services Sold | $6.5B |
Operating Income | $2.6B |
Selling General And Administrative | $6B |
Research And Development | $1.6B |
Operating Expenses | $7.6B |
Investment Income Net | - |
Net Interest Income | -$198M |
Interest Income | $107M |
Interest Expense | $387M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.3B |
Income Before Tax | $2.3B |
Income Tax Expense | $436M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $1.8B |
Comprehensive Income Net Of Tax | - |
Ebit | $2.7B |
Ebitda | $3.9B |
Net Income | $1.9B |
Field | Value (USD) |
---|---|
Total Assets | $39B |
Total Current Assets | $6.9B |
Cash And Cash Equivalents At Carrying Value | $414M |
Cash And Short Term Investments | $414M |
Inventory | $2.8B |
Current Net Receivables | $2.6B |
Total Non Current Assets | $32B |
Property Plant Equipment | $3.7B |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $6.7B |
Intangible Assets Excluding Goodwill | $6.7B |
Goodwill | $17B |
Investments | - |
Long Term Investments | $555M |
Short Term Investments | - |
Other Current Assets | $1.1B |
Other Non Current Assets | - |
Total Liabilities | $17B |
Total Current Liabilities | $6.4B |
Current Accounts Payable | $960M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.8B |
Total Non Current Liabilities | $11B |
Capital Lease Obligations | $527M |
Long Term Debt | $8.8B |
Current Long Term Debt | $1.8B |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $11B |
Other Current Liabilities | $3B |
Other Non Current Liabilities | $634M |
Total Shareholder Equity | $22B |
Treasury Stock | - |
Retained Earnings | $2.7B |
Common Stock | $17M |
Common Stock Shares Outstanding | $1.5B |
Field | Value (USD) |
---|---|
Operating Cashflow | $3.4B |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.3B |
Capital Expenditures | $790M |
Change In Receivables | - |
Change In Inventory | -$228M |
Profit Loss | - |
Cashflow From Investment | -$5.7B |
Cashflow From Financing | $1.8B |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $0 |
Dividend Payout Common Stock | $0 |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $230M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $1.8B |
Field | Value (USD) |
---|---|
Gross Profit | $10B |
Total Revenue | $17B |
Cost Of Revenue | $6.5B |
Costof Goods And Services Sold | $6.5B |
Operating Income | $2.6B |
Selling General And Administrative | $6B |
Research And Development | $1.6B |
Operating Expenses | $7.6B |
Investment Income Net | - |
Net Interest Income | -$198M |
Interest Income | $107M |
Interest Expense | $387M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.3B |
Income Before Tax | $2.3B |
Income Tax Expense | $436M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $1.8B |
Comprehensive Income Net Of Tax | - |
Ebit | $2.7B |
Ebitda | $3.9B |
Net Income | $1.9B |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.